Divis Laboratories has informed that a meeting of the Board of Directors of the Company will be held on May 24, 2014, to consider and approve the audited financial results for the year ended March 31, 2014 and to recommend Dividend on Equity Shares for the year ended March 31, 2014, if any. Further, Company has informed that the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from May 17, 2014 to May 26, 2014 as per the Code of Conduct of the Company under the SEBI Prohibition of Insider Trading Regulations, 1992.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: